Lista de obras -

1110Identification of Formulations and Vaccine Schedules of a Trivalent Group B Streptococcus Vaccine for Further Development in Non-pregnant and Pregnant Women.

artículo científico publicado en 2014

1335Transfer and Persistence of Antibodies in Infants Following Maternal Immunization with an Investigational Trivalent Group B Streptococcus Vaccine.

artículo científico publicado en 2014

A Multi-Vector, Multi-Envelope HIV-1 Vaccine

artículo científico publicado en 2007

A five-residue HIV envelope helper T cell determinant: does this peptide-MHC interaction leave the binding groove half empty?

artículo científico publicado en 2002

A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women

artículo científico publicado en 2016

A recombinant Sendai virus is controlled by CD4+ effector T cells responding to a secreted human immunodeficiency virus type 1 envelope glycoprotein

artículo científico publicado en 2007

Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy

artículo científico publicado en 2017

Application of the polyvalent approach to HIV-1 vaccine development

artículo científico publicado en 2005

CD8+ T-cells: are they sufficient to prevent, contain or eradicate HIV-1 infection?

artículo científico publicado en 2005

Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary?

artículo científico publicado en 2005

Clustering of Th Cell Epitopes on Exposed Regions of HIV Envelope Despite Defects in Antibody Activity ⬇️

artículo científico publicado el 15 de octubre de 2003

Do the Immunosuppressive Drugs used as Treatment for Graft-versus-host Disease Directly Inhibit Lymphoid Tumor Cell Growth? ⬇️

artículo científico publicado el 1 de enero de 2003

First phase I clinical trial of an HIV-1 subtype D gp140 envelope protein vaccine: immune activity induced in all study participants

artículo científico publicado en 2008

Functional activity of maternal and cord antibodies elicited by an investigational group B streptococcus trivalent glycoconjugate vaccine in pregnant women

artículo científico publicado en 2018

Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial

artículo científico publicado en 2016

HIV vaccine rationale, design and testing.

artículo científico publicado en 2005

HIV vaccines: brief review and discussion of future directions.

artículo científico publicado en 2005

HIV-1 envelope T cell epitope "hotspots " among mice and humans and among CD4+ and CD8+ T cell subpopulations

artículo científico publicado en 2007

HIV-1 vaccine development: tackling virus diversity with a multi-envelope cocktail.

artículo científico publicado en 2008

Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials

artículo científico publicado en 2010

How Basic Immunological Principles May Instruct the Design of a Successful HIV-Type 1 Vaccine

artículo científico publicado en 2020

Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

artículo científico publicado en 2009

Incidence and serotype distribution of invasive group B streptococcal disease in young infants: a multi-country observational study

artículo científico publicado en 2015

Inhibition of ex vivo-expanded cytotoxic T-lymphocyte function by high-dose cyclosporine

artículo científico publicado en 2003

Lessons learnt from enrolment and follow up of pregnant women and their infants in clinical trials in South Africa, a low-middle income country

artículo científico publicado en 2015

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

artículo científico publicado en 2009

Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine: A Randomized Controlled Trial

artículo científico publicado en 2016

Minor components of a multi-envelope HIV vaccine are recognized by type-specific T-helper cells

artículo científico publicado en 2004

Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV.

artículo científico publicado en 2005

Preclinical and clinical development of a multi-envelope, DNA-virus-protein (D-V-P) HIV-1 vaccine

artículo científico publicado en 2009

Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?

artículo científico publicado en 2014

Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus

artículo científico publicado en 2005

Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV.

artículo científico publicado en 2004

Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B

artículo científico publicado en 2007

Safety and immunogenicity of a second dose of an investigational maternal trivalent Group B streptococcus vaccine in non-pregnant women 4-6 years after a first dose: results from a phase 2 trial

scientific article published on 08 August 2019

Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children

artículo científico publicado en 2014

Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults

artículo científico publicado en 2020

Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial

artículo científico publicado en 2016

Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults

artículo científico publicado en 2004

Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats

artículo científico publicado en 2014

Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections

scientific article published on May 2008

Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model

artículo científico publicado en 2014

T cell epitope "hotspots" on the HIV Type 1 gp120 envelope protein overlap with tryptic fragments displayed by mass spectrometry

artículo científico publicado en 2005

The HIV pandemic: a forgotten crisis?

artículo científico publicado en 2005

Variation in reported neonatal group B streptococcal disease incidence in developing countries

artículo científico publicado en 2012

Lista de obras de

1110Identification of Formulations and Vaccine Schedules of a Trivalent Group B Streptococcus Vaccine for Further Development in Non-pregnant and Pregnant Women.

1335Transfer and Persistence of Antibodies in Infants Following Maternal Immunization with an Investigational Trivalent Group B Streptococcus Vaccine.

A Multi-Vector, Multi-Envelope HIV-1 Vaccine

A five-residue HIV envelope helper T cell determinant: does this peptide-MHC interaction leave the binding groove half empty?

A randomized, observer-blind Phase Ib study to identify formulations and vaccine schedules of a trivalent Group B Streptococcus vaccine for use in non-pregnant and pregnant women

A recombinant Sendai virus is controlled by CD4+ effector T cells responding to a secreted human immunodeficiency virus type 1 envelope glycoprotein

Antibody Kinetics and Response to Routine Vaccinations in Infants Born to Women Who Received an Investigational Trivalent Group B Streptococcus Polysaccharide CRM197-Conjugate Vaccine During Pregnancy

Application of the polyvalent approach to HIV-1 vaccine development

CD8+ T-cells: are they sufficient to prevent, contain or eradicate HIV-1 infection?

Clade, Country and Region-specific HIV-1 Vaccines: Are they necessary?

Clustering of Th Cell Epitopes on Exposed Regions of HIV Envelope Despite Defects in Antibody Activity ⬇️

Do the Immunosuppressive Drugs used as Treatment for Graft-versus-host Disease Directly Inhibit Lymphoid Tumor Cell Growth? ⬇️

First phase I clinical trial of an HIV-1 subtype D gp140 envelope protein vaccine: immune activity induced in all study participants

Functional activity of maternal and cord antibodies elicited by an investigational group B streptococcus trivalent glycoconjugate vaccine in pregnant women

Group B streptococcus vaccination in pregnant women with or without HIV in Africa: a non-randomised phase 2, open-label, multicentre trial

HIV vaccine rationale, design and testing.

HIV vaccines: brief review and discussion of future directions.

HIV-1 envelope T cell epitope "hotspots " among mice and humans and among CD4+ and CD8+ T cell subpopulations

HIV-1 vaccine development: tackling virus diversity with a multi-envelope cocktail.

Heterologous Prime-Boost HIV-1 Vaccination Regimens in Pre-Clinical and Clinical Trials

How Basic Immunological Principles May Instruct the Design of a Successful HIV-Type 1 Vaccine

Human PIV-2 recombinant Sendai virus (rSeV) elicits durable immunity and combines with two additional rSeVs to protect against hPIV-1, hPIV-2, hPIV-3, and RSV.

Incidence and serotype distribution of invasive group B streptococcal disease in young infants: a multi-country observational study

Inhibition of ex vivo-expanded cytotoxic T-lymphocyte function by high-dose cyclosporine

Lessons learnt from enrolment and follow up of pregnant women and their infants in clinical trials in South Africa, a low-middle income country

Long-term outcome of EBV-specific T-cell infusions to prevent or treat EBV-related lymphoproliferative disease in transplant recipients

Maternal Immunization With an Investigational Trivalent Group B Streptococcal Vaccine: A Randomized Controlled Trial

Minor components of a multi-envelope HIV vaccine are recognized by type-specific T-helper cells

Multi-envelope HIV-1 vaccine devoid of SIV components controls disease in macaques challenged with heterologous pathogenic SHIV.

Preclinical and clinical development of a multi-envelope, DNA-virus-protein (D-V-P) HIV-1 vaccine

Prevention of group B streptococcal disease in the first 3 months of life: would routine maternal immunization during pregnancy be cost-effective?

Recombinant Sendai virus as a novel vaccine candidate for respiratory syncytial virus

Recombinant Sendai virus expressing the G glycoprotein of respiratory syncytial virus (RSV) elicits immune protection against RSV.

Respiratory syncytial virus (RSV) fusion protein expressed by recombinant Sendai virus elicits B-cell and T-cell responses in cotton rats and confers protection against RSV subtypes A and B

Safety and immunogenicity of a second dose of an investigational maternal trivalent Group B streptococcus vaccine in non-pregnant women 4-6 years after a first dose: results from a phase 2 trial

Safety and immunogenicity of an intranasal Sendai virus-based human parainfluenza virus type 1 vaccine in 3- to 6-year-old children

Safety and immunogenicity of an intranasal sendai virus-based vaccine for human parainfluenza virus type I and respiratory syncytial virus (SeVRSV) in adults

Safety and immunogenicity of an investigational maternal trivalent group B streptococcus vaccine in healthy women and their infants: a randomised phase 1b/2 trial

Safety and immunogenicity of intranasal murine parainfluenza virus type 1 (Sendai virus) in healthy human adults

Sendai virus recombinant vaccine expressing a secreted, unconstrained respiratory syncytial virus fusion protein protects against RSV in cotton rats

Sendai virus recombinant vaccine expressing hPIV-3 HN or F elicits protective immunity and combines with a second recombinant to prevent hPIV-1, hPIV-3 and RSV infections

Sendai virus-based RSV vaccine protects against RSV challenge in an in vivo maternal antibody model

T cell epitope "hotspots" on the HIV Type 1 gp120 envelope protein overlap with tryptic fragments displayed by mass spectrometry

The HIV pandemic: a forgotten crisis?

Variation in reported neonatal group B streptococcal disease incidence in developing countries